Skip to main content
Top
Published in: Rheumatology International 11/2017

01-11-2017 | Observational Research

Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis

Authors: Aniko Rentka, Annamaria Nagy, Jolan Harsfalvi, Gabriella Szucs, Zoltan Szekanecz, Rudolf Gesztelyi, Peter Szodoray, Adam Kemeny-Beke

Published in: Rheumatology International | Issue 11/2017

Login to get access

Abstract

The aim of this study was to evaluate the association between clinical signs and symptoms of dry eye disease (DED) in patients with systemic sclerosis (SSc). This cross-sectional observational study included 19 SSc patients and 19 normal subjects with no ocular symptoms or ocular surface disorders. Clinical parameters included tear film break-up time (tBUT), Schirmer I, lissamine green (LG) dye, and tear film osmolarity tests, tear production, and tear secretion flow. For assessment of the dry eye symptoms, the Ocular Surface Disease Index (OSDI) questionnaire was administered to all patients. The following mean values were found in SSc patients: OSDI 33.6 ± 19.86; osmolarity of the tear fluid 310.8 mOsmol/l ± 14.47; tBUT time 5.158 ± 2.328 s; Schirmer I test 5.395 mm/5 min; LG grading score 2.026 ± 0.8893; collected tear fluid volume 6.397 ± 2.761 µl. The calculated average tear velocity was 4.654 ± 1.963 µl/min. A significant correlation was found between the OSDI as a subjective parameter and disease duration. Early recognition of dry eye symptoms, a possible extra-intestinal manifestation of SSc, should be included in the check up of the disease to reduce ocular complications. The objective tear functional tests were strongly influenced by individual factors like age and disease duration.
Literature
1.
go back to reference Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120. doi:10.1002/art.24676 CrossRefPubMed Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120. doi:10.​1002/​art.​24676 CrossRefPubMed
3.
go back to reference Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223–235CrossRefPubMed Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223–235CrossRefPubMed
4.
go back to reference Gomes Bde A, Santhiago MR, Magalhães P, Kara-Junior N, Azevedo MN, Moraes HV Jr (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo) 66:379–385CrossRef Gomes Bde A, Santhiago MR, Magalhães P, Kara-Junior N, Azevedo MN, Moraes HV Jr (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo) 66:379–385CrossRef
5.
go back to reference Hunzelmann N, Genth E, Krieg T et al (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47:1185–1192. doi:10.1093/rheumatology/ken179 CrossRef Hunzelmann N, Genth E, Krieg T et al (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47:1185–1192. doi:10.​1093/​rheumatology/​ken179 CrossRef
10.
go back to reference Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S (1997) Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:1395–1401CrossRefPubMed Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S (1997) Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:1395–1401CrossRefPubMed
11.
go back to reference Barboza MN, Barboza GN, de Melo GM, Sato E, Dantas MC, Dantas PE, Felberg S (2008) Correlation between signals and symptoms of dry eye in Sjögren’s syndrome patients. Arq Bras Oftalmol 71:547–552CrossRefPubMed Barboza MN, Barboza GN, de Melo GM, Sato E, Dantas MC, Dantas PE, Felberg S (2008) Correlation between signals and symptoms of dry eye in Sjögren’s syndrome patients. Arq Bras Oftalmol 71:547–552CrossRefPubMed
13.
go back to reference Vitale S, Goodman LA, Reed GF, Smith JA (2004) Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren’s syndrome-related dry eye. Health Qual Life Outcomes 2:44CrossRefPubMedPubMedCentral Vitale S, Goodman LA, Reed GF, Smith JA (2004) Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren’s syndrome-related dry eye. Health Qual Life Outcomes 2:44CrossRefPubMedPubMedCentral
14.
go back to reference Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:762–770CrossRefPubMed Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:762–770CrossRefPubMed
15.
go back to reference Bron A, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640–650CrossRefPubMed Bron A, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640–650CrossRefPubMed
16.
go back to reference Lopin E, Deveney T, Asbell PA (2009) Impression cytology: recent advances and applications in dry eye disease. Ocul Surf 7:93–110CrossRefPubMed Lopin E, Deveney T, Asbell PA (2009) Impression cytology: recent advances and applications in dry eye disease. Ocul Surf 7:93–110CrossRefPubMed
17.
go back to reference Walt J (2004) Ocular Surface Disease Index (OSDI) administration and scoring manual. Allergan, Irvine Walt J (2004) Ocular Surface Disease Index (OSDI) administration and scoring manual. Allergan, Irvine
18.
go back to reference U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef
19.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
20.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590CrossRef
21.
go back to reference Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621CrossRefPubMed Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621CrossRefPubMed
22.
go back to reference Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA (2010) An objective approach to dry eye disease severity. Investig Ophthalmol Vis Sci 51:6125–6130. doi:10.1167/iovs.10-5390 CrossRef Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA (2010) An objective approach to dry eye disease severity. Investig Ophthalmol Vis Sci 51:6125–6130. doi:10.​1167/​iovs.​10-5390 CrossRef
23.
go back to reference Foulks GN (2003) Challenges and pitfalls in clinical trials of treatments for dry eye. Ocul Surf 1:20–30CrossRefPubMed Foulks GN (2003) Challenges and pitfalls in clinical trials of treatments for dry eye. Ocul Surf 1:20–30CrossRefPubMed
24.
go back to reference Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007) Ocul Surf 5:108–152 Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007) Ocul Surf 5:108–152
25.
go back to reference Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, Geerling G, Figueiredo F, Lemp MA (2014) Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 92:161–166. doi:10.1111/aos.12012 CrossRefPubMed Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, Geerling G, Figueiredo F, Lemp MA (2014) Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 92:161–166. doi:10.​1111/​aos.​12012 CrossRefPubMed
27.
go back to reference Şahin M, Yüksel H, Şahin A, Cingü AK, Türkcü FM, Kaya S, Yazmalar L, Batmaz İ (2016) Evaluation of the Anterior segment parameters of the patients with scleroderma. Ocul Immunol Inflamm 30:1–6. doi:10.3109/09273948.2015.1115079 Şahin M, Yüksel H, Şahin A, Cingü AK, Türkcü FM, Kaya S, Yazmalar L, Batmaz İ (2016) Evaluation of the Anterior segment parameters of the patients with scleroderma. Ocul Immunol Inflamm 30:1–6. doi:10.​3109/​09273948.​2015.​1115079
28.
go back to reference de Gomes AFB, Santhiago MR, de Azevedo MN, Moraes HV Jr (2012) Evaluation of dry eye signs and symptoms in patients with systemic sclerosis. Graefes Arch Clin Exp Ophthalmol 250:1051–1056. doi:10.1007/s00417-012-1938-3 CrossRef de Gomes AFB, Santhiago MR, de Azevedo MN, Moraes HV Jr (2012) Evaluation of dry eye signs and symptoms in patients with systemic sclerosis. Graefes Arch Clin Exp Ophthalmol 250:1051–1056. doi:10.​1007/​s00417-012-1938-3 CrossRef
29.
go back to reference Stucchi CA, Geiser JD (1967) Eye manifestations of generalized scleroderma. Aspects in common with Sjogren’s Syndrome. Doc Ophthalmol 22:72–110CrossRefPubMed Stucchi CA, Geiser JD (1967) Eye manifestations of generalized scleroderma. Aspects in common with Sjogren’s Syndrome. Doc Ophthalmol 22:72–110CrossRefPubMed
30.
go back to reference Wangkaew S, Kasitanon N, Sivasomboon C, Wichainun R, Sukitawut W, Louthrenoo W (2006) Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol 24:213–221PubMed Wangkaew S, Kasitanon N, Sivasomboon C, Wichainun R, Sukitawut W, Louthrenoo W (2006) Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol 24:213–221PubMed
31.
go back to reference Anand R (1985) Ocular involvement in a case of scleroderma. Indian J Ophthalmol 33:71–72PubMed Anand R (1985) Ocular involvement in a case of scleroderma. Indian J Ophthalmol 33:71–72PubMed
32.
go back to reference Rasker JJ, Jayson MI, Jones DE, Matthews R, Burton JL, Rhys Davies E, Burton PA (1990) Sjögren’s syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 19:57–65CrossRefPubMed Rasker JJ, Jayson MI, Jones DE, Matthews R, Burton JL, Rhys Davies E, Burton PA (1990) Sjögren’s syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 19:57–65CrossRefPubMed
33.
go back to reference Mancel E, Janin A, Gosset D, Hatron PY, Gosselin B (1993) Conjunctival biopsy in scleroderma and primary Sjögren’s syndrome. Am J Ophthalmol 115:792–799CrossRefPubMed Mancel E, Janin A, Gosset D, Hatron PY, Gosselin B (1993) Conjunctival biopsy in scleroderma and primary Sjögren’s syndrome. Am J Ophthalmol 115:792–799CrossRefPubMed
Metadata
Title
Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis
Authors
Aniko Rentka
Annamaria Nagy
Jolan Harsfalvi
Gabriella Szucs
Zoltan Szekanecz
Rudolf Gesztelyi
Peter Szodoray
Adam Kemeny-Beke
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3794-2

Other articles of this Issue 11/2017

Rheumatology International 11/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.